Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in subjects with cerebrovascular disease. Journal of Hypertension. 2007;25:699-705.
[Plenary] ADVANCE – results of the blood pressure arm. In: Chinese Society of Endocrinology 2007 Annual Scientific Meeting. Chinese Society of Endocrinology 2007 Annual Scientific Meeting. Wuhan, China; 2007..
Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus. Contemporary Clinical Trials. 2007;28:6-17.
Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region. Journal of Hypertension. 2007;25:1205-13.
The experience of patients admitted with acute coronary syndromes (ACS) to hospitals in China. Proceedings of the 55th annual Scientific Meeting of the Cardiac society of Australia and New Zealand. 2007;16;(Suppl 2):S76-S77..
The experience of patients with acute coronary syndromes admitted to hospitals in China. Heart. 2007;94:554-60.
The relationship between total cholesterol and the risk of major cardiovascular diseases is similar amongst individuals with and without diabetes across populations in the Asia Pacific region. 55th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand . 2007;16(Suppl 2):S81-S82.
Update on ADVANCE and a proposal for an international glucose lowering trialists’ collaboration (plenary). In: ACCORD Meeting of Investigators. ACCORD Meeting of Investigators. Washington, USA; 2007..
What trials are required for the polypill? Clinical Trials Symposium. In: 55th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. 55th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Christchurch, New Zealand; 2007..
ADVANCE: breaking new ground in type 2 diabetes. Proceedings of the XXII National Congress of Italian Society of Hypertension. 2006;24(Suppl 5):S22-8. [IF 4.364]..
ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes. Blood Pressure. 2006;15:340-6. [Impact Factor 1.391]..
An evaluation of metabolic risks for coronary death in the Asia Pacific Region. Diabetes Research and Clinical Practice. 2006;74:274-281. [Impact Factor 1.823].